Candida Variety in the Oral Cavity of Mexican Subjects with Type 2 Diabetes Mellitus and TLR2 Gene Expression
Clinics and Practice · 27.02.2024 · 14 (2) · 417-425
DOI: 10.3390/clinpract14020031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinics and Practice, online erschienen am 27.02.2024. Verfasst von Nadia Mabel Pérez-Vielma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sección de Estudios de Posgrado e Investigación, Centro Interdisciplinario de Ciencias de la Salud Unidad Santo Tomás, Instituto Politécnico Nacional…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Politécnico Nacional, SIP.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
The aim was to diagnose Candida in the oral cavity of subjects with type 2 diabetes mellitus (T2DM) using a genotyping technique and compare the results with those from conventional diagnosis by Papanicolaou (Pap) staining.
Methods
Palatal mucosa smears were performed on 18 dental care patients diagnosed with T2DM and grade I, II, and III prosthetic stomatitis who met the inclusion criteria; 18 healthy control subjects were also included in the study. Hemoglobin A1c (HbA1c) levels were determined from total blood. Using exfoliative cytology, the Pap staining technique was used to diagnose candidiasis. Exfoliative cytology was also used for molecular diagnosis; DNA was obtained for Candida genotyping, and RNA was used for gene expression studies.
Results
Clinical patterns indicated that all subjects were positive for Candida; however, Pap analysis revealed only three positive subjects, whereas end-point polymerase chain reaction (PCR) analysis revealed 15 subjects with some type of Candida. The most common Candida species found were Candida guilliermondii (38.8%), Candida krusei (33.3%), Candida tropicalis, and Candida lusitaniae (22.2%). Interestingly, the coexpression of different species of Candida was found in various patients. In all patients, HbA1c levels were increased. Gene expression analysis showed a significant decrease (p ≤ 0.05) in TLR2 expression in positive subjects, whereas TLR4 expression did not differ significantly among patients.
Conclusions
The end-point PCR technique showed better sensitivity for the diagnosis of Candida when compared with the diagnosis by Pap staining. T2DM subjects showed an increased presence of C. guilliermondii that was correlated with decreased TLR2 expression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sección de Estudios de Posgrado e Investigación, Centro Interdisciplinario de Ciencias de la Salud Unidad Santo Tomás, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
- Laboratorio de Biología Molecular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
ORCID-Profile: Ángel Miliar-García
Förderung
- Instituto Politécnico Nacional
- SIP
Zitieren
APA
Pérez-Vielma, N. M., Gómez-López, M., Martínez-Godínez, M. L. Á., Luna-Torres, A. L., Domínguez López, A., & Miliar-García, Á. (2024). Candida Variety in the Oral Cavity of Mexican Subjects with Type 2 Diabetes Mellitus and TLR2 Gene Expression. Clinics and Practice, 14(2), 417-425. https://doi.org/10.3390/clinpract14020031
Vancouver
Pérez-Vielma NM, Gómez-López M, Martínez-Godínez MLÁ, Luna-Torres AL, Domínguez López A, Miliar-García Á. Candida Variety in the Oral Cavity of Mexican Subjects with Type 2 Diabetes Mellitus and TLR2 Gene Expression. Clinics and Practice. 2024;14(2):417-425. doi:10.3390/clinpract14020031
BibTeX
@article{PrezVielma2024,
author = {Pérez-Vielma, Nadia Mabel and Gómez-López, Modesto and Martínez-Godínez, María de Los Ángeles and Luna-Torres, Ana Laura and Domínguez López, Aarón and Miliar-García, Ángel},
title = {Candida Variety in the Oral Cavity of Mexican Subjects with Type 2 Diabetes Mellitus and TLR2 Gene Expression},
journal = {Clinics and Practice},
year = {2024},
volume = {14},
number = {2},
pages = {417--425},
doi = {10.3390/clinpract14020031}
}
EUVIMED